High-dose melphalan and autologous stem cell transplantation increases survival
A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation ...
Oct 26, 2011
0
0